16.80p+10.55 (+168.80%)03 Jul 2024, 17:19
Jump to:
Crism Therapeutics Corporation Fundamentals
Company Name | Crism Therapeutics Corporation | Last Updated | 2024-07-03 |
---|---|---|---|
Industry | Other Industrial Metals & Mining | Sector | Basic Materials |
Shares in Issue | 32.678 m | Market Cap | £5.49 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -$1.10 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0 | Debt Equity Ratio | 0 |
Asset Equity Ratio | 1.1605 | Cash Equity Ratio | 1.0630 |
Quick Ratio | 6.6224 | Current Ratio | 7.23 |
Price To Book Value | 0.6262 | ROCE | 0 |
Crism Therapeutics Corporation Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Crism Therapeutics Corporation Company Financials
Assets | 2023 | 2022 | 2021 |
---|---|---|---|
Tangible Assets | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 |
Investments | 0 | 0 | 0 |
Total Fixed Assets | 0 | $25.20 m | $24.45 m |
Stocks | 0 | 0 | 0 |
Debtors | 0 | 0 | -$9,000.00 |
Cash & Equivalents | $4.38 m | $3.48 m | $6.68 m |
Other Assets | 0 | 0 | 0 |
Total Assets | $4.79 m | $28.74 m | $31.24 m |
Liabilities | 2023 | 2022 | 2021 |
---|---|---|---|
Creditors within 1 year | $662,000.00 | $745,000.00 | $1.13 m |
Creditors after 1 year | 0 | $176,000.00 | 0 |
Other Liabilities | 0 | 0 | $159,000.00 |
Total Liabilities | $662,000.00 | $921,000.00 | $1.13 m |
Net assets | $4.12 m | $27.82 m | $30.11 m |
Equity | 2023 | 2022 | 2021 |
---|---|---|---|
Called up share capital | $80.79 m | $80.79 m | $80.45 m |
Share Premium | $4.28 m | $4.28 m | $4.28 m |
Profit / Loss | -$2.39 m | -$2.60 m | -$1.79 m |
Other Equity | $4.12 m | $27.82 m | $30.11 m |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | $4.12 m | $27.82 m | $30.11 m |
Ratios | 2023 | 2022 | 2021 |
---|---|---|---|
Debt Ratio | 0 | 0 | 0 |
Debt-to-Equity | 0 | 0 | 0 |
Assets / Equity | 1.1605 | 1.1605 | 1.1605 |
Cash / Equity | 1.0630 | 1.0630 | 1.0630 |
EPS | -$0.27 | -$0.26 | -$0.21 |
Cash Flow | 2023 | 2022 | 2021 |
---|---|---|---|
Cash from operating activities | 0 | 0 | 0 |
Cashflow before financing | 0 | 0 | 0 |
Increase in Cash | $714,000.00 | -$3.06 m | $4.21 m |
Income | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | 0 | 0 | 0 |
Cost of sales | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 |
Operating Profit | -$2.26 m | -$2.60 m | -$1.79 m |
Pre-Tax profit | -$2.39 m | -$2.60 m | -$1.79 m |
Crism Therapeutics Corporation Company Background
Sector | Basic Materials |
---|---|
Activities | Crism Therapeutics Corp formerly Amur Minerals Corp is a cash shell company. |
Latest Interim Date | 25 Sep 2023 |
Latest Fiscal Year End Date | 10 May 2024 |
Crism Therapeutics Corporation Directors
Appointed | Name | Position |
---|---|---|
2011-08-09 | Mr. George William O'Neale Eccles | Non-Executive Director |
2024-05-29 | Mr. Thomas Edward Bowens | Non-Executive Director |
2009-12-31 | Mr. William Philip McLucas | Non-Executive Director |
2009-12-31 | Mr. Eric David McAuslan | Non-Executive Director |
2021-06-30 | Mr. Brian Charles Savage | Non-Executive Director |
2024-05-29 | Mr. Robert William Schafer | Non-Executive Director,Chairman |
2024-05-29 | Mr. Robin Jay Young BSc | Executive Director,Chief Executive Officer |
2011-10-03 | Mr. David Fain Wood BA,MBA | Chief Financial Officer & Co Secretary |
2011-08-09 | Mr. David Straker-Smith | Non-Executive Director |
2024-05-29 | Mr. Paul Terence Gazzard | Non-Executive Director |
2020-05-20 | Mr. Ljupco Lou Naumovski | Non-Executive Director |
2021-06-30 | Mr. Adam Habib | Executive Director,President |
2024-06-03 | Mr. Gerald Douglas Beaney | Non-Executive Director |
2024-05-31 | Mr. Andrew James Webb | Executive Director,Chief Executive Officer |
2024-05-31 | Dr. Christopher McConville | Executive Director,Chief Scientific Officer |
Crism Therapeutics Corporation Contact Details
Company Name | Crism Therapeutics Corp |
---|---|
Address | Kingston Chambers, P.O. Box 173, Tortola, Road Town, null |
Telephone | |
Website | https://www.amurminerals.com |
Crism Therapeutics Corporation Advisors
Solicitor | Norton Rose Fulbright (Central Europe) LLP |
---|---|
Phone | +7 4999245101 |
Nominated Adviser | SP Angel |
---|---|
Phone | +44 2034700470 |
Fax | +44 2076291341 |
Financial Adviser | SP Angel |
---|---|
Phone | +44 2034700470 |
Fax | +44 2076291341 |
Stockbroker | SP Angel |
---|---|
Phone | +44 2034700470 |
Fax | +44 2076291341 |
Financial PR Adviser | Yellow Jersey PR Ltd |
---|
Solicitor | Fieldfisher |
---|---|
Phone | +44 2078614000 |
Registrar | Capita Asset Services |
---|---|
Phone | +44 8704027573 |
Nominated Adviser | RBC Capital Markets |
---|---|
Phone | 020 7653 4000 |
Fax | 020 7029 7900 |
Auditor | BDO LLP |
---|---|
Phone | +44 2074865888 |
Fax | +44 2074873686 |
Stockbroker | RBC Capital Markets |
---|---|
Phone | (020) 7653 4000 |
Fax | (020) 7029 7900 |
Financial PR Adviser | Tavistock Communications Ltd |
---|---|
Phone | +44 2079203150 |
Fax | +44 2079203151 |
Solicitor | Maples and Calder |
---|
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
![Sharesmagazine cover](/images/daily-email-mag-cover.jpg)
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Close Brothers Group PLC | 461.00 | 10.82 |
W.A.G Payment Solutions PLC | 67.40 | 8.71 |
Mobico Group PLC | 52.75 | 7.96 |
Hochschild Mining PLC | 186.00 | 7.27 |
Hammerson PLC | 29.46 | 6.20 |
Inchcape PLC | 790.50 | 5.75 |
Fallers
Company | Price | % Chg |
---|---|---|
Jd Sports Fashion PLC | 112.90 | -4.00 |
Indivior PLC | 1,163.00 | -3.96 |
Puretech Health PLC | 179.00 | -3.03 |
Wood Group (John) PLC | 199.90 | -2.01 |
Cmc Markets PLC | 324.50 | -1.82 |
Carnival PLC | 1,263.50 | -1.40 |